• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe.

作者信息

Thevissen Karin, Jacobs Cato, Holtappels Michelle, Toda Mitsuru, Verweij Paul, Wauters Joost

机构信息

KU Leuven Centre of Microbial and Plant Genetics, Leuven, Belgium.

KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory for Clinical Infectious and Inflammatory Disorders, Herestraat 49, 3000, Leuven, Belgium.

出版信息

Crit Care. 2020 Mar 11;24(1):84. doi: 10.1186/s13054-020-2808-8.

DOI:10.1186/s13054-020-2808-8
PMID:32160910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7066742/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b673/7066742/4d173d1d9eee/13054_2020_2808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b673/7066742/4d173d1d9eee/13054_2020_2808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b673/7066742/4d173d1d9eee/13054_2020_2808_Fig1_HTML.jpg

相似文献

1
International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe.重症监护病房中流感相关肺曲霉病（IAPA）的国际调查：结果表明在欧洲以外地区认知度较低且可能存在诊断不足的情况。
Crit Care. 2020 Mar 11;24(1):84. doi: 10.1186/s13054-020-2808-8.
2
Correction to: International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe.对《重症监护病房中流感相关肺曲霉病（IAPA）的国际调查：结果表明欧洲以外地区对此认识不足且可能存在诊断不足》的勘误
Crit Care. 2020 Apr 29;24(1):186. doi: 10.1186/s13054-020-02901-x.
3
Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis.重症流感相关性侵袭性肺曲霉病患者的临床特征和结局：系统评价和荟萃分析。
J Hosp Infect. 2022 Feb;120:98-109. doi: 10.1016/j.jhin.2021.11.016. Epub 2021 Nov 26.
4
Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.哮喘患者流感相关侵袭性肺曲霉病（IAPA）风险较高：瑞士一项关于危重症流感患者中 IAPA 的多中心队列研究。
Influenza Other Respir Viruses. 2023 Jan;17(1):e13059. doi: 10.1111/irv.13059. Epub 2022 Nov 16.
5
Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study.瑞典重症监护病房患者中与流感相关的侵袭性曲霉病：一项前瞻性多中心队列研究
Infect Dis (Lond). 2024 Feb;56(2):110-115. doi: 10.1080/23744235.2023.2273381. Epub 2023 Dec 18.
6
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.流感相关或 COVID-19 相关肺曲霉病中肺上皮细胞和髓样固有免疫：一项观察性研究。
Lancet Respir Med. 2022 Dec;10(12):1147-1159. doi: 10.1016/S2213-2600(22)00259-4. Epub 2022 Aug 24.
7
Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.重症监护病房中的侵袭性肺曲霉病：当前挑战与最佳实践
APMIS. 2023 Nov;131(11):654-667. doi: 10.1111/apm.13316. Epub 2023 Apr 25.
8
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.泊沙康唑预防危重症流感患者侵袭性肺曲霉病（POSA-FLU）的随机、开放标签、概念验证试验。
Intensive Care Med. 2021 Jun;47(6):674-686. doi: 10.1007/s00134-021-06431-0. Epub 2021 May 29.
9
Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis.危重症患者中流感相关肺曲霉病的患病率、危险因素、临床特征及结局：一项系统评价和荟萃分析
Chest. 2024 Mar;165(3):540-558. doi: 10.1016/j.chest.2023.09.019. Epub 2023 Sep 22.
10
Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy.通过测定支气管肺泡灌洗液和血清中的半乳甘露聚糖来检测流感相关的肺曲霉病：我们是否应添加（1,3）-β-D-葡聚糖以提高检测效果。
Crit Care. 2020 Jun 5;24(1):294. doi: 10.1186/s13054-020-03030-1.

引用本文的文献

1
Fungal Pathogens as Causes of Acute Respiratory Illness in Hospitalized Veterans: Frequency of Fungal Positive Test Results Using Rapid Immunodiagnostic Assays.真菌病原体作为住院退伍军人急性呼吸道疾病的病因：使用快速免疫诊断检测方法真菌检测呈阳性结果的频率
J Fungi (Basel). 2023 Apr 8;9(4):456. doi: 10.3390/jof9040456.
2
Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients.侵袭性肺曲霉病：不仅是一种影响免疫抑制患者的疾病。
Diagnostics (Basel). 2023 Jan 26;13(3):440. doi: 10.3390/diagnostics13030440.
3
Transcriptome analysis reveals increased abundance and diversity of opportunistic fungal pathogens in nasopharyngeal tract of COVID-19 patients.

本文引用的文献

1
High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada.高比例的流感相关侵袭性肺曲霉病可能并非普遍现象：来自加拿大阿尔伯塔省的一项回顾性队列研究。
Clin Infect Dis. 2020 Oct 23;71(7):1760-1763. doi: 10.1093/cid/ciaa007.
2
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.美国传染病学会临床实践指南：2018年季节性流感诊断、治疗、化学预防及机构性疫情管理更新版。
Clin Infect Dis. 2019 Mar 5;68(6):895-902. doi: 10.1093/cid/ciy874.
3
转录组分析揭示新冠病毒患者鼻咽部机会性真菌病原体丰度和多样性增加。
PLoS One. 2023 Jan 19;18(1):e0278134. doi: 10.1371/journal.pone.0278134. eCollection 2023.
4
Liposomal amphotericin B-the future.脂质体两性霉素 B——未来。
J Antimicrob Chemother. 2022 Nov 25;77(Suppl_2):ii21-ii34. doi: 10.1093/jac/dkac353.
5
Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.哮喘患者流感相关侵袭性肺曲霉病（IAPA）风险较高：瑞士一项关于危重症流感患者中 IAPA 的多中心队列研究。
Influenza Other Respir Viruses. 2023 Jan;17(1):e13059. doi: 10.1111/irv.13059. Epub 2022 Nov 16.
6
An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?新型冠状病毒肺炎相关真菌感染概述：大流行一年后我们了解了哪些？
Braz J Microbiol. 2022 Jun;53(2):759-775. doi: 10.1007/s42770-022-00704-6. Epub 2022 Mar 21.
7
Novel Clinical and Laboratorial Challenges in Aspergillosis.曲霉病的新型临床与实验室挑战
Microorganisms. 2022 Jan 24;10(2):259. doi: 10.3390/microorganisms10020259.
8
Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta-analysis.流感患者侵袭性肺曲霉病的发病率、危险因素和死亡率：系统评价和荟萃分析。
Mycoses. 2022 Feb;65(2):152-163. doi: 10.1111/myc.13410. Epub 2021 Dec 22.
9
COVID-19-associated mucormycosis: Case report and systematic review.COVID-19 相关毛霉病：病例报告和系统评价。
Travel Med Infect Dis. 2021 Nov-Dec;44:102148. doi: 10.1016/j.tmaid.2021.102148. Epub 2021 Aug 26.
10
COVID-19-Associated Pulmonary Aspergillosis at an Academic Medical Center in the Midwestern United States.美国中西部一学术医疗中心的 COVID-19 相关肺曲霉病。
Mycopathologia. 2021 Aug;186(4):499-505. doi: 10.1007/s11046-021-00564-y. Epub 2021 Jun 18.
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.
严重流感合并侵袭性肺曲霉病：流行病学、诊断和治疗。
Curr Opin Infect Dis. 2018 Dec;31(6):471-480. doi: 10.1097/QCO.0000000000000504.
4
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病：一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.
5
Influenza.流感。
Nat Rev Dis Primers. 2018 Jun 28;4(1):3. doi: 10.1038/s41572-018-0002-y.
6
Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.支气管肺泡灌洗术中的半乳甘露聚糖：一种用于诊断重症监护病房患者曲霉病的工具。
Am J Respir Crit Care Med. 2008 Jan 1;177(1):27-34. doi: 10.1164/rccm.200704-606OC. Epub 2007 Sep 20.